Prévisions du marché de la découverte d\'anticorps en Asie-Pacifique jusqu\'en 2030 - Analyse régionale - par type d\'anticorps (anticorps monoclonaux, anticorps polyclonaux et autres), nature (humaine et humanisée, chimérique et murine), services (affichage de phages, hybridome, animal transgénique, cellule unique et affichage de levure) et utilisateur final (sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et autres)
La prolifération de l\'industrie biotechnologique dans les régions en développement stimule le marché de la découverte d\'anticorps en Asie-Pacifique
La précision remarquable des anticorps dans l\'identification des antigènes en fait des outils inestimables pour les scientifiques et les cliniciens. Dans la biotechnologie moderne, les anticorps sont nécessaires dans de nombreux processus, de la recherche fondamentale aux évaluations médicales innovantes. Le développement d\'anticorps thérapeutiques a ouvert de nouvelles voies dans le traitement de diverses maladies, démontrant la capacité de transformation de ces particules. Les anticorps sont également essentiels dans les diagnostics basés sur les anticorps car ils fournissent des approches précises et fiables pour l\'identification des maladies. Français Le soutien croissant des gouvernements, l\'augmentation des partenariats public-privé, l\'évolution constante des profils de maladies et l\'augmentation des activités de financement améliorent considérablement les performances des industries biotechnologiques dans des régions telles que l\'Asie-Pacifique.
Selon l\'Organisation de coopération et de développement économiques (OCDE), la Chine était un pionnier en termes de dépenses de R&D en 2019. Des investissements importants encouragent l\'adoption de technologies avancées dans le secteur de la santé. Les gouvernements de pays de régions telles que l\'Asie offrent des incitations fiscales, des terrains moins chers et des investissements directs pour encourager les entreprises de biotechnologie à étendre leurs capacités et à renforcer leurs capacités. Ainsi, des pays comme Taiwan, la Malaisie, l\'Inde, la Chine, Singapour et le Japon sont parmi les destinations les plus avantageuses pour les industries biotechnologiques. En outre, ces pays asiatiques se concentrent davantage sur l\'utilisation des avancées en génomique, en protéomique et en biomarqueurs pour des applications diagnostiques et thérapeutiques. Par conséquent, la prolifération continue des industries biotechnologiques dans les régions en développement devrait créer des opportunités pour le marché de la découverte d\'anticorps dans les années à venir.
Aperçu du marché de la découverte d\'anticorps en Asie-Pacifique
Le marché de la découverte d\'anticorps en Asie-Pacifique est segmenté en Chine, au Japon, en Inde, en Corée du Sud, en Australie et dans le reste de l\'Asie-Pacifique. La Chine représentait la plus grande part du marché en 2022, et l\'Inde devrait enregistrer un TCAC important sur le marché au cours de la période de prévision. L\'industrie biopharmaceutique en Chine connaît un changement considérable, passant d\'un paysage axé sur les génériques à un pôle d\'innovation florissant. De plus, les progrès de l\'industrialisation et l\'application de nouveaux médicaments, de dispositifs médicaux haut de gamme et de techniques contribuent à la croissance du marché de la découverte d\'anticorps en Chine.
La Chine connaît une recrudescence de la prévalence des maladies cardiovasculaires et d\'autres maladies chroniques. Selon le Journal of Biomedical and Environmental Science, près de 330 millions de personnes du pays ont souffert de maladies cardiovasculaires en 2021. Les produits à base d\'anticorps sont essentiels au développement de nouvelles thérapies contre les maladies cardiovasculaires. Par conséquent, une prévalence croissante des maladies cardiaques déclenche le besoin de découverte d\'anticorps. Français Avec l\'aide des centres de recherche, des séquences d\'anticorps peuvent être recherchées, de nouveaux anticorps peuvent être développés et les anticorps existants peuvent être optimisés. Selon le classement de l\'Institut Scimago, la Chine comptait près de 170 centres de recherche médicale en 2022, suivie du Japon (72), de l\'Australie (53) et de l\'Inde (17). En outre, le nombre croissant d\'acteurs du marché se concentrant sur les pays d\'Asie-Pacifique pour leur expansion géographique et d\'autres stratégies de croissance, le nombre croissant de centres de recherche et une augmentation notable du financement gouvernemental alimentent la croissance du marché de la découverte d\'anticorps en Asie-Pacifique.
Chiffre d\'affaires et prévisions du marché de la découverte d\'anticorps en Asie-Pacifique jusqu\'en 2030 (milliards de dollars américains)
Segmentation du marché de la découverte d\'anticorps en Asie-Pacifique
Le marché de la découverte d\'anticorps en Asie-Pacifique est classé en type d\'anticorps, nature, services, utilisateur final et pays.
En fonction du type d\'anticorps, le marché de la découverte d\'anticorps en Asie-Pacifique est segmenté en anticorps monoclonaux, anticorps polyclonaux et autres. Français Le segment des anticorps monoclonaux détenait la plus grande part de marché de la découverte d\'anticorps en Asie-Pacifique en 2022.
En termes de nature, le marché de la découverte d\'anticorps en Asie-Pacifique est segmenté en humain et humanisé, chimérique et murin. Le segment humain et humanisé détenait la plus grande part de marché de la découverte d\'anticorps en Asie-Pacifique en 2022.
Par services, le marché de la découverte d\'anticorps en Asie-Pacifique est divisé en affichage de phages, hybridome, animal transgénique, cellule unique et affichage de levure. Le segment de l\'affichage de phages détenait la plus grande part de marché de la découverte d\'anticorps en Asie-Pacifique en 2022.
Sur la base de l\'utilisateur final, le marché de la découverte d\'anticorps en Asie-Pacifique est classé en sociétés pharmaceutiques et biotechnologiques, laboratoires de recherche et autres. Le segment des sociétés pharmaceutiques et biotechnologiques détenait la plus grande part de marché de la découverte d\'anticorps en Asie-Pacifique en 2022.
Sur la base du pays, le marché de la découverte d\'anticorps en Asie-Pacifique est classé en Chine, Japon, Inde, Corée du Sud, Australie et reste de l\'Asie-Pacifique. La Chine a dominé le marché de la découverte d\'anticorps en Asie-Pacifique en 2022.
Charles River Laboratories International Inc, BioDuro LLC, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp et Biocytogen Pharmaceuticals Beijing Co Ltd. sont quelques-unes des principales sociétés opérant sur le marché de la découverte d\'anticorps en Asie-Pacifique.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.1 Asia Pacific Antibody Discovery Market – Key Market Dynamics
4.2 Market Drivers
4.2.1 Increasing Investments in Research & Development
4.2.2 Rising Incidence of Cancer
4.3 Market Restraints
4.3.1 High Cost of Production
4.4 Market Opportunities
4.4.1 Proliferation of Biotechnology Industry in Developing Regions
4.5 Future Trends
4.5.1 Developments for Custom Antibodies
4.6 Impact of Drivers and Restraints:
5. Antibody Discovery Market – Asia Pacific Market Analysis
5.1 Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020–2030
6. Asia Pacific Antibody Discovery Market Analysis – by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7. Asia Pacific Antibody Discovery Market Analysis – by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8. Asia Pacific Antibody Discovery Market Analysis – by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9. Asia Pacific Antibody Discovery Market Analysis – by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10. Asia Pacific Antibody Discovery Market – Country Analysis
10.1 Asia Pacific Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Asia Pacific: Antibody Discovery Market – Revenue and Forecast Analysis – by Country
10.1.1.1 China
10.1.1.1.1 Overview
10.1.1.1.2 China: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 China: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 China: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 China: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 China: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Japan
10.1.1.2.1 Overview
10.1.1.2.2 Japan: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Japan: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Japan: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Japan: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Japan: Antibody Discovery Market Breakdown, by End User
10.1.1.3 India
10.1.1.3.1 Overview
10.1.1.3.2 India: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 India: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 India: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 India: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 India: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Australia
10.1.1.4.1 Overview
10.1.1.4.2 Australia: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Australia: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Australia: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Australia: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Australia: Antibody Discovery Market Breakdown, by End User
10.1.1.5 South Korea
10.1.1.5.1 Overview
10.1.1.5.2 South Korea: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 South Korea: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 South Korea: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 South Korea: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 South Korea: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Asia Pacific
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Asia Pacific: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 BioDuro LLC
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Sartorius AG
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Aragen Life Sciences Ltd
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Twist Bioscience Corp
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Biocytogen Pharmaceuticals Beijing Co Ltd
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Asia Pacific Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 4. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 5. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 6. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 7. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 8. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 9. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 10. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 11. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 12. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 13. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 14. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 15. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 16. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 17. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 18. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 19. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 20. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 21. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 22. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 23. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Antibody Type
Table 24. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Nature
Table 25. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by Services
Table 26. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million) – by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Asia Pacific Antibody Discovery Market Segmentation, by Country
Figure 2. Impact Analysis of Drivers and Restraints
Figure 3. Asia Pacific Antibody Discovery Market Revenue (US$ Million), 2020 – 2030
Figure 4. Asia Pacific Antibody Discovery Market Share (%) – by Antibody Type (2022 and 2030)
Figure 5. Monoclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 6. Polyclonal Antibodies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 7. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 8. Asia Pacific Antibody Discovery Market Share (%) – by Nature (2022 and 2030)
Figure 9. Human and Humanized: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 10. Chimeric: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 11. Murine: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 12. Asia Pacific Antibody Discovery Market Share (%) – by Services (2022 and 2030)
Figure 13. Phage Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 14. Hybridoma: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 15. Transgenic Animal: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 16. Yeast Display: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 17. Single Cell: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 18. Asia Pacific Antibody Discovery Market Share (%) – by End User (2022 and 2030)
Figure 19. Pharmaceutical and Biotechnology Companies: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 20. Research Laboratories: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 21. Others: Asia Pacific Antibody Discovery Market – Revenue and Forecast to 2030 (US$ Million)
Figure 22. Asia Pacific: Antibody Discovery Market, by Key Country – Revenue (2022) (US$ Million)
Figure 23. Asia Pacific: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 24. China: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 25. Japan: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 26. India: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 27. Australia: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 28. South Korea: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 29. Rest of Asia Pacific: Antibody Discovery Market – Revenue and Forecast to 2030(US$ Million)
Figure 30. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- BioDuro LLC
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Asia Pacific antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the Asia Pacific antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.